Autoimmune Disease Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component, By Test Type, By Disease Type, By End User, By Region and Competition, 2020-2030F
Global Autoimmune Disease Diagnostics Market was valued at USD 5.74 billion in 2024 and is expected to reach USD 9.64 billion by 2030 with a CAGR of 9.03% during the forecast period. The Global Autoimmune Disease Diagnostics Market refers to the worldwide industry focused on the diagnosis and testing of autoimmune diseases. Autoimmune diseases are a group of disorders in which the immune system mistakenly attacks the body's own healthy tissues, leading to various health problems. The market for autoimmune disease diagnostics encompasses a wide range of products, services, and technologies aimed at identifying and monitoring these conditions. Autoimmune diseases are a group of more than 100 chronic, debilitating conditions that affect approximately 3% of the US population, or about 10 million people. Some of the most common autoimmune diseases include obesity, cardiovascular diseases, type 2 diabetes mellitus, and all cancers.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 5.74 Billion
Market Size 2030
USD 9.64 Billion
CAGR 2025-2030
9.03%
Fastest Growing Segment
Systemic Autoimmune Disease Diagnostics
Largest Market
North America
Key Market Drivers
Rising Prevalence of Autoimmune Diseases
Autoimmune diseases have become a growing global health concern, affecting millions of people worldwide. These conditions occur when the body's immune system mistakenly targets its own tissues, leading to chronic inflammation and a wide range of health issues. As the prevalence of autoimmune diseases continues to rise, the Global Autoimmune Disease Diagnostics Market is experiencing significant growth. Autoimmune diseases are no longer considered rare. They have reached epidemic proportions, with millions of people across the globe suffering from various autoimmune conditions. Common autoimmune diseases include rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, Crohn's disease, and type 1 diabetes. The sheer volume of patients seeking diagnosis and treatment has boosted the demand for autoimmune disease diagnostics. Early diagnosis is crucial for managing autoimmune diseases effectively. Many of these conditions exhibit subtle symptoms in their early stages, making accurate and timely diagnosis challenging. However, as awareness about autoimmune diseases increases, individuals are more likely to seek medical attention when experiencing symptoms, driving the need for diagnostic tests that can confirm or rule out these conditions.
Moreover, the rising prevalence of autoimmune diseases has coincided with significant technological advancements in healthcare. Diagnostic tools and techniques have evolved rapidly, providing healthcare professionals with more accurate and efficient ways to detect autoimmune diseases. These advancements include serology tests, genetic testing, imaging modalities, and biomarker-based assays. Such innovations enhance the diagnostic capabilities and contribute to early intervention. The growth of the autoimmune disease diagnostics market is also linked to the trend of personalized medicine. Tailoring treatments based on an individual's unique genetic and immunological profile is gaining prominence. To prescribe personalized therapies effectively, precise diagnostics are required to identify the specific autoimmune disease and its severity, enabling clinicians to choose the most suitable treatment options. For instance, a study published in the American Journal of Managed Care (AJMC) in May 2021 reported an estimated prevalence of 276 cases per million adults for scleroderma in the U.S. A recent study found that autoimmune disorders now affect about one in ten individuals, with 80-100 known autoimmune diseases affecting more than 14 million Americans.
Key Market Challenges
Complexity of Autoimmune Diseases
One of the fundamental challenges in autoimmune disease diagnostics is the sheer complexity of these conditions. Autoimmune diseases can present with a wide array of symptoms, and their underlying mechanisms are often intricate and multifaceted. This complexity makes it challenging to develop diagnostic tests that are both accurate and comprehensive.
Key Market Trends
Advances in Biomarker Discovery
Biomarkers play a crucial role in autoimmune disease diagnostics. Ongoing research is leading to the discovery of novel biomarkers that can improve diagnostic accuracy. These biomarkers are expected to become integral in identifying autoimmune diseases at earlier stages and monitoring disease progression more effectively.
Key Market Players
Abbott Laboratories
Siemens Healthineers AG
Roche Diagnostics Corp
Beckman Coulter Inc
SQI Diagnostics Inc
EUROIMMUN Medizinische Labordiagnostika AG
Aesku Diagnostics GmbH & Co KG
INOVA Diagnostics Inc
Crescendo Bioscience LLC
bioMerieux SA
Report Scope:
In this report, the Global Autoimmune Disease Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Autoimmune Disease Diagnostics Market, By Component:
Instruments
Reagents
Consumables
Autoimmune Disease Diagnostics Market, By Test Type:
Routine Laboratory Tests
Inflammatory Markers
Antibodies & Immunologic Tests
Others
Autoimmune Disease Diagnostics Market, By Disease Type:
Systemic Autoimmune Disease Diagnostics
Rheumatoid Arthritis
Ankylosing Spondylitis
Systemic Lupus Erythematosus
Others
Localized Autoimmune Disease Diagnostics
Multiple Sclerosis
Type 1 Diabetes
Hashimoto's Thyroiditis
Others
Autoimmune Disease Diagnostics Market, By End User:
Hospitals & Clinics
Diagnostic Centers
Others
Autoimmune Disease Diagnostics Market, By Region:
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Asia-Pacific
China
Japan
India
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Autoimmune Disease Diagnostics Market.
Available Customizations:
Global Autoimmune Disease Diagnostics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Autoimmune Disease Diagnostics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Component (Instruments, Reagents, Consumables)
5.2.2. By Test Type (Routine Laboratory Tests, Inflammatory Markers, Antibodies & Immunologic Tests, Others)
5.2.3. By Disease Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics)